VIVUS to Present at Four Upcoming Investor Conferences

VIVUS to Present at Four Upcoming Investor Conferences

MOUNTAIN VIEW, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc.
(Nasdaq:VVUS) today announced that management will present an overview of the
company at four investment conferences during the months of April and May

The conference presentation schedule is as follows:

Needham 12th Annual Healthcare Conference
April 30, 2013, 1:40pm EDT
Westin Grand Central Hotel
New York, NY

Bank of America Merrill Lynch 2013 Health Care Conference
May 15, 2013, 4:20pm PDT
Encore at the Wynn
Las Vegas, NV

BioEquity Europe 2013
May 23, 2013, 10:30am CEST
Sheraton Hotel
Stockholm, Sweden

Deutsche Bank 38th Annual dbAccess Health Care Conference
May 30, 2013, 3:30pm EDT
Westin Boston Waterfront Hotel
Boston, MA

A live webcast and 30-day archive of the presentations will be available at


VIVUS is a biopharmaceutical company commercializing and developing
innovative, next-generation therapies to address unmet needs in obesity, sleep
apnea, diabetes and sexual health. For more information about the company,
please visit

Certain statements in this press release are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements may be identified by the use of forward-looking words such as
"anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely,"
"may," "plan," "potential," "predict," "opportunity" and "should," among
others. There are a number of factors that could cause actual events to differ
materially from those indicated by such forward-looking statements. VIVUS does
not undertake an obligation to update or revise any forward-looking
statements. Investors should read the risk factors set forth in VIVUS' Form
10-K for the year ending December 31, 2012, and periodic reports filed with
the Securities and Exchange Commission.

         Timothy E. Morris
         Chief Financial Officer
         Financial Media Relations:
         Joele Frank, Wilkinson Brimmer Katcher
         Jennifer Beugelmans
         (212) 895-8692
         Investor Relations:
         The Trout Group
         Brian Korb
Press spacebar to pause and continue. Press esc to stop.